top of page
Nitib price 140 mg (Ibrutinib) contains a drug moiety known as Ibrutinib. It is the type of drug used to treat cancers of the blood, including mantle cell lymphoma, chronic lymphocytic leukemia, and macroglobulinemia of Waldenstrom A small fraction of the drug prevents β-cell multiplication and survival by irreversibly binding to Bruton's protein tyrosine kinase (BTK), blocking BTK will inhibit the β-cell receptor pathway which, It is often abnormally active in β-cell cancers. Nitib price 140 mg (Ibrutinib) permanently binds to a protein called BTK, which is vital in β cells. It is a medication prescribed to treat or cure adult patients with blood cancers such as chronic graft-versus-host disease, marginal zone lymphoma, Waldenstrom's macroglobulinemia, mantle cell lymphoma and smallpox lymphocytic lymphoma, chronic lymphocytic leukemia. Nitib 140 mg (Ibrutinib) is the first-line treatment for people newly diagnosed with chronic lymphocytic leukemia (CLL) and in need of treatment. These capsules can also be used for reversing or regressing chronic lymphocytic leukemia (CLL).

Nitib 140mg Capsule

  • Cancer

OTHER PRODUCTS

APPROVED BY GOVERNMENT

LEGIT BRANDS

HIGH QUALITY PRODUCTS

PROMPT TRANSPORTATION

Blue Textured Wall

MEDICAL DISCLAIMER:All content found on the HEXA HEALTHCARE PVT LTD Website, including: text, images, audio, or other formats were created for informational purposes only. Offerings for continuing education credits are clearly identified and the appropriate target audience is identified. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website.

If you think you may have a medical emergency, call your doctor or go to the emergency department, or immediately. HEXA HEALTHCARE PVT LTD does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on HEXA HEALTHCARE PVT LTD Website. Reliance on any information provided by HEXA HEALTHCARE PVT LTD, HEXA HEALTHCARE PVT LTD employees, contracted writers, or medical professionals presenting content for publication to HEXA HEALTHCARE PVT LTD is solely at your own risk.

The Site may contain health- or medical-related materials or discussions regarding sexually explicit disease states. If you find these materials offensive, you may not want to use our Site. The Site and its Content are provided on an "as is" basis.

Links to educational content not created by HEXA HEALTHCARE PVT LTD are taken at your own risk. HEXA HEALTHCARE PVT LTD is not responsible for the claims of external websites and education companies.

General Advisory: We advise you to stick to medication routine (or medication adherence), i.e. to take medications as prescribed – the right dose, at the right time, in the right way and frequency. Not taking medicines as prescribed by a doctor or instructed by a pharmacist could lead to disease getting worse, hospitalization, even death.

All Trademarks, Brands and Service marks that appear on this website belong to their respective owner.

bottom of page